Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
RNAZ

Overview Financials Analysis Smart Money

TransCode Therapeutics, Inc.

RNAZ · NASDAQ

Analyze with AI

Filings1

Total reported value$57.9K

Manager	Shares	Value	Change
ACT CAPITAL MANAGEMENT, LLC	6.5K	$57.9K	0.0%

SymbolRNAZ

Market Cap$8.3M

IPO Date2021-07-08

CEOPhilippe Calais

Employees7

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

cbdMD, Inc.

YCBD

$2.29

+60.13%

Agape ATP Corporation

ATPC

$0.143

+58.89%

Inspirato Incorporated

ISPO

$4.16

+46.30%

Aditxt, Inc.

ADTX

$1.97

+38.73%

Akanda Corp.

AKAN

$0.9822

+31.84%

Peers

IN8bio, Inc.

INAB · NASDAQ

$1.49

-0.67%

Lyra Therapeutics, Inc.

LYRA · NASDAQ

$4.01

+3.76%

Aptevo Therapeutics Inc.

APVO · NASDAQ

$1.09

-1.36%

Galecto, Inc.

GLTO · NASDAQ

$28.65

-4.50%

Phio Pharmaceuticals Corp.

PHIO · NASDAQ

$1.08

-0.46%

HCW Biologics Inc.

HCWB · NASDAQ

$1.89

+6.17%

Kiora Pharmaceuticals, Inc.

KPRX · NASDAQ

$2.12

+4.12%

Aprea Therapeutics, Inc.

APRE · NASDAQ

$0.92

+0.99%

Bolt Biotherapeutics, Inc.

BOLT · NASDAQ

$5.41

-0.73%

Acurx Pharmaceuticals, Inc.

ACXP · NASDAQ

$3.68

+2.51%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.